SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001645113-23-000022
Filing Date
2023-02-23
Accepted
2023-02-23 07:04:29
Documents
13
Period of Report
2023-02-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nvcr-20230223.htm   iXBRL 8-K 32529
2 EX-99.1 nvcr-20221231xpr1.htm EX-99.1 137548
  Complete submission text file 0001645113-23-000022.txt   318879

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nvcr-20230223.xsd EX-101.SCH 1999
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nvcr-20230223_lab.xml EX-101.LAB 24053
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nvcr-20230223_pre.xml EX-101.PRE 12577
7 EXTRACTED XBRL INSTANCE DOCUMENT nvcr-20230223_htm.xml XML 10814
Mailing Address NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Y9 JE2 4UF
Business Address NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Y9 JE2 4UF 44 (0)15 3475 6700
NovoCure Ltd (Filer) CIK: 0001645113 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37565 | Film No.: 23655884
SIC: 3841 Surgical & Medical Instruments & Apparatus